We are currently working to coordinate filming of the event. It is our hope that video footage from the evening, including the panel discussion, will then be shared on our website so that all those with Ocular Melanoma nationally will benefit from listening to the experts.
Tuesday 18th July 2017 – 6:00pm to 8:30pm
Level 8, East Wing, Wesley Hospital, 451 Coronation Drive, Brisbane
Paid parking is available at The Wesley as well as limited on street parking.
Public transport is easily accessible.
$5.00 per person, register here
Dr Sunil Warrier
Dr Warrier obtained his medical degree from the Flinders University of South Australia. He then underwent residency training in medicine and surgery at The Royal Adelaide Hospital and completed a Masters degree in Medicine, before moving to Queensland to undertake specialist training in ophthalmology. After completing the rigorous training and exams set by The Royal Australian and New Zealand College of Ophthalmologists, he received a scholarship from the Prevent Blindness Foundation to further study diseases of the Retina, Glaucoma and Ocular Oncology. Dr Warrier also received further specialist training in Ocular Oncology at the Liverpool Ocular Oncology Service (NHS Centre for Excellence), located within St Paul’s Eye Unit in the United Kingdom.
He has several publications in peer-reviewed journals and continues this interest in research to this day. He has a passion for teaching both medical students and trainee specialists, both in his private practice and via his public appointment at The Mater Hospital, Brisbane.
Dr Kelly Brooks
Kelly is a scientific researcher at QIMR Berghofer in Professor Nick Hayward’s Oncogenonics research team. She has been working on melanoma for 9 years both in Brisbane and also in Manchester, England. It was during her time in Manchester that Kelly’s research became focused on uveal melanoma. Her research aims to understand the biology underlying the development, maintenance and progression of uveal melanoma. By understanding the biological consequences of common mutations Kelly’s work aims to identify key biological pathways that can be targeted for the development of effective and selective treatments for metastatic uveal melanoma.
Jane is a research nurse with a career-long interest in melanoma who acts as the study participant liaison. Her main role consists of recruiting participants, obtaining biological samples as well as collating and updating genotype, family history, epidemiologic, environmental risk factor, clinical and outcome information for study participants. She coordinates the Queensland component of a large international melanoma genetics research project and management of the Oncogenomics Laboratory biospecimen bank.